Patent directory · USPTO A61K / A61P
Patents matching “BioCryst Pharmaceuticals, Inc.”
65 pharma patents match "BioCryst Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 65 pharmaceutical patents matching "BioCryst Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8163703
Hepatitis C therapies
granted -
US 8133870
Therapeutic furopyrimidines and thienopyrimidines
granted -
US 7994139
Antiviral therapeutic agents
granted -
US 7514410
Hepatitis C therapies
granted -
US 7429571
Therapeutic furopyrimidines and thienopyrimidines
granted -
US 7388002
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
granted -
US 7045535
Compounds useful for inhibiting paramyxovirus neuraminidase
expired -
US 6946554
Process for the preparation of 9-deazaguanine derivatives
expired -
US 6936719
Biaryl compounds as serine protease inhibitors
expired -
US 6699994
Biaryl compounds as serine protease inhibitors
expired -
US 6660719
Inhibiting T-Cell proliferation
expired -
US 6656915
Inhibiting T-cell proliferation
expired -
US 6576786
Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
expired -
US 6562861
Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
expired -
US 6458799
Deazaguanine analog, preparation thereof and use thereof
expired -
US 6410594
Substituted cyclopentane compounds useful as neuraminidase inhibitors
expired -
US 6387923
Imminoribitol PNP inhibitors, preparation thereof and use thereof
expired